Comparative evaluation of the nitrate reductase assay and the resazurin microtitre assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs

Brazilian Journal of Microbiology

Volumn 39, Issue 1, 2008, Pages 16-20

  Sanchotene, Karine O ^a   Von Groll, Andrea ^a   Ramos, Daniela ^a   Scholante, Ana B ^a   Honscha, Gunther ^a   Valença, Mariana ^a   Scaini, Carlos J ^a   Da Silva, Pedro E A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

Drug resistance; Mycobacterium tuberculosis; Nitrate reductase assay; Susceptibility tests; Tuberculosis

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 42349116815     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822008000100004     Document Type: Article

References (18)

1. Abate, G.; Mshana, R.N.; Miorner, H. (1998). Evaluation of a colorimetric assay base don 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tertazolim bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis., 2 (12), 1011-1018.
2. Ängeby, K.A.; Klintz, I.; Hoffner, S.E. (2002). Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol., 40 (2), 553-555.
3. Barroso, E.C.; Mota, R.M.S.; Santos, R.O.; Sousa, A.L.O.; Barroso, J.B.; Rodrigues, J.L.N. (2003). Risk factors for acquired multidrug-resistant tuberculosis. J. Pneumol., 29 (2), 89-97.
4. Canetti, G.; Froman, S.; Grosset, J.; Hauduroy, P.; Langerova, M.; Mahler, H.; et al. (1963). Mycobacteria: Laboratory Methods for Testing Drug Sensitivity and Resistance. Bull. World Health Organ., 29, 565-578.
5. Coll, P. (2003). Fármacos con actividad frente a Mycobacterium tuberculosis. Enferm Infecc. Microbiol. Clín., 21 (6), 299-308.
6. Cox, H.S.; Orozco, J.D.; Male, R.; Ruesch-Gerdes, S.; Falzon, D.; Small, I.; Doshetov, D.; Kebede, Y.; Aziz, M. (2004). Multidrug-resistant tuberculosis in central Asia. Emerg Infect Dis., 10, 865-872.
7. Franzblau, S.G.; Witzig, R.S.; Mclaughlin, J.C.; Torres, P.; Madico, G.; Hernandez, A.; Degnan, M.T.; Cook, M.B.; Quenzer, V.K.; Fergunson, R. M.; Gilman, R. H. (1998). Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay. J. Clin. Microbiol., 36 (2), 362-366.
8. Kumar, M.; Khan, I.A.; Verma, V.; Kalyan, N.; Qazi, G.N. (2005). Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis., 9 (8), 939-941.
9. Lemus, D.; Martin, A.; Montoro, E.; Potaels, F.; Palomino, J.C. (2004). Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother., 54 (1), 130-133.
10. Martin, A.; Camacho, M.; Portaels, F.; Palomino, J.C. (2003). Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother., 47 (11), 3616-3619.
11. Martin, A.; Palomino, J.C.; Portaels, F. (2005). Rapid detection of ofloxacin Resitance in Mycobacterium tuberculosis by Two Low-Cost Colorimetric Methods: Resazurin and Nitrate Reductase Assays. J. Clin. Microbiol., 43 (4), 1612-1616.
12. Mengatto, L.; Chiani, Y.; Imaz, M.S. (2006). Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst. Oswaldo Cruz, 10 (5), 535-542.
13. Montoro, E.; Lemus, D.; Echemendia, M.; Martin, A.; Portaels, F.; Palomino, J.C. (2005). Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J. Antimicrob. Chemother., 55 (4), 500-505.
14. Palomino, J.C.; Portaels, F. (1999). Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetric assay. Eur J Clin Microbiol Infect Dis., 18, 380-383.
15. Telenti, A.; Imboden P.; Marchesi, F.; et al. (1993). Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet., 341 (10), 647-650.
16. Tenover, F.C. (1999). Manual and Automated System for Microbial Identification. In: _. Manual of Clinical Microbiology. ASM Press, Washington.
17. Organizaçao Muncial da Saúde (2003). Treatment of Tuberculosis. Guidelines for nacional programmes. WHO/CDS/TB/2003.313.
18. Organização Mundial da Saúde (2006). Global Tuberculosis Control: Surveillang, Planning, Financing. Available at: 〈http://www.who.int/mediacentre/factsheets/fs104/en/#strategy〉. 01 fev. 2007.